Robert Erhardt Heisner Ii, DOCTOR OF PHARMACY Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 S Washington St, Du Quoin, IL 62832 Phone: 618-542-2575 Fax: 618-542-3688 |
Emily Bauersachs, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 S Washington St, Du Quoin, IL 62832 Phone: 618-542-2575 |
Kurt Hermann, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 N Washington St, Du Quoin, IL 62832 Phone: 618-542-1016 |
Brad Galli, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 S Washington St, Du Quoin, IL 62832 Phone: 618-542-2575 Fax: 618-542-3688 |
Beth Keith-mudgette, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 E Grantway St, Du Quoin, IL 62832 Phone: 618-542-2488 |
Mr. Alan Gene Morris, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 N Washington St, Du Quoin, IL 62832 Phone: 618-542-2146 |
Michael Dean Melvin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 E Grantway St, Du Quoin, IL 62832 Phone: 161-820-1118 |
Sydnie Chard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 215 E Grantway St, Du Quoin, IL 62832 Phone: 618-542-2488 |
News Archive
Anticentromere and isolated nucleolar autoantibodies are prevalent in systemic sclerosis patients with pulmonary arterial hypertension, but they do not predict survival, US research shows.
With "less than 1,000 days to go until the 2015 deadline for the world's Millennium Development Goals (MDGs) ..., [t]he international community is busy examining the progress we've made and all the work remaining if we are to realize the vision that was laid out 12 years ago," Nigel Chapman, CEO of Plan International, writes in the Huffington Post's "Impact" blog.
Food banks should be used more consistently rather than only during emergencies to better address food insecurity and related health issues, a joint study by researchers at UT Southwestern Medical Center and economists at the University of Dallas shows.
Alchemia Limited, today announced the initiation of recruitment for a Phase II clinical study of its lead cancer drug HA-Irinotecan in Small Cell Lung Cancer (SCLC). Two patients have received their first doses of therapy. This investigator sponsored trial is being conducted at Monash Cancer Centre, Southern Health and Peninsula Oncology Centre in Melbourne, Victoria.
› Verified 4 days ago